Mar 25, 2025 / 12:00PM GMT
Operator
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Medacta Group full year 2024 results conference call. (Operator Instructions) At this time, I would like to turn the conference over to Mr. Francesco Siccardi, CEO of Medacta Group.
Please go ahead, sir.
Francesco Siccardi - Medacta Group SA - Chief Executive Officer, Member of the Group Executive Management
Thank you, and good afternoon, everybody. Welcome to Medacta 2024 full year results. I am here with Corrado Farsetta, Medacta's CFO, and we will guide you through the presentation we released this morning. First of all, let's just remember our disclaimers. So the highlights of 2024 started with our revenue release that were already published few weeks ago, a very good growth over 16% in constant currency, surpassing EUR590 million.
And this is combined with a good excellent profitability with a 28% EBITDA margin in constant currency or EUR27.1 million in euro, a good increase of 19.4% over 2023. The net profit as well increased by almost 54%
Full Year 2024 Medacta Group SA Earnings Call Transcript
Mar 25, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers